Perianal Crohn's disease
Perianal CD · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Fistulising/abscess-forming perianal disease is a disabling Crohn's phenotype needing combined medical and surgical management; MRI defines anatomy and anti-TNF therapy with seton drainage is the mainstay.
Red flags
- Undrained perianal abscess (sepsis)
- Increasing pain, swelling, fever
- Faecal incontinence (sphincter involvement)
- Suspicion of anorectal cancer in longstanding fistula
Assessment
Differential diagnosis
- Cryptoglandular (non-Crohn's) perianal fistula/abscess
- Hidradenitis suppurativa
- Anorectal malignancy
- Sexually transmitted proctitis (LGV)
- Tuberculous fistula
Investigations
- Pelvic MRI (fistula anatomy, abscess, classification)
- Examination under anaesthesia by colorectal surgeon
- Endoscopy to assess rectal inflammation
- Faecal calprotectin, CRP, FBC
- Hepatitis B/C, TB, VZV screen before biologics
Management
- Confirm Crohn's and assess rectal/luminal disease activity
- Obtain pelvic MRI to map fistula tracts and detect abscess
- Arrange examination under anaesthesia with drainage of any abscess and seton placement
- Control sepsis before/alongside immunosuppression — never immunosuppress undrained sepsis
- Start an anti-TNF biologic (infliximab first-line) as the key medical therapy
- Combine with a thiopurine to optimise biologic levels and durability where appropriate
- Add an antibiotic course (metronidazole ± ciprofloxacin) for active sepsis/symptoms
- Treat concurrent rectal inflammation to improve fistula healing
- Use therapeutic drug monitoring — perianal disease needs higher biologic trough levels
- Consider definitive surgery (fistulotomy for simple tracts; advancement flap, LIFT, or stem cells for complex) once inflammation controlled
- Reassess with repeat MRI before removing setons; long-term maintenance therapy and surveillance
Drugs & doses
Infliximab 5 mg/kg IV at 0, 2, 6 weeks then 8-weekly (aim higher trough levels)
Metronidazole 400 mg PO three times daily
Ciprofloxacin 500 mg PO twice daily
Azathioprine 2–2.5 mg/kg PO once daily (combination)
Disposition
Joint IBD-colorectal MDT; EUA and seton by colorectal surgery, medical therapy by IBD team.
Complications & pitfalls
- Recurrent perianal sepsis/abscess
- Anal sphincter damage and incontinence
- Rectovaginal fistula
- Anorectal carcinoma (longstanding fistula)
- Proctectomy/stoma for refractory disease
Exam pearls
- Always drain sepsis and place setons BEFORE escalating immunosuppression
- Perianal fistulising Crohn's needs higher anti-TNF trough levels than luminal disease
- MRI is the standard for mapping tracts and confirming healing before seton removal
- Combination anti-TNF plus thiopurine improves fistula outcomes
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.